StockNews.AI
BKYI
StockNews.AI
117 days

BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance

1. BKYI received a non-compliance notice from Nasdaq on April 17, 2025. 2. Company timely filed its Form 10-K on April 23, regaining Nasdaq compliance. 3. Compliance issues had no immediate impact on BKYI's stock trading. 4. BKYI provides biometric IAM solutions, securing access for over 40 million users. 5. The matter with Nasdaq has now been resolved.

4m saved
Insight
Article

FAQ

Why Neutral?

The non-compliance notice did not impact stock trading immediately. Historical examples suggest temporary non-compliance does not drastically affect price.

How important is it?

The resolution restores investor confidence; however, past compliance issues linger. Swift actions imply strong company governance.

Why Short Term?

The quick resolution improves outlook, but prior compliance issues cast doubt. Similar scenarios show transient effects with immediate recovery.

Related Companies

COMPATYSDUO
April 24, 2025 16:30 ET  | Source: BIO-key International, Inc. HOLMDEL, N.J. , April 24, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced today that on April 17, 2025, it received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024. The notification letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market. On April 23, 2025, the Company filed its Form 10-K for the year ended December 31, 2024 with the SEC. On April 24, 2025, the Company received notice from Nasdaq stating that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that the matter has been closed. About BIO-key International, Inc. (www.BIO-key.com)BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions. Engage with BIO-key  Corporate Facebook:LinkedIn:X:https://www.facebook.com/BIOkeyInternational/https://www.linkedin.com/company/bio-key-international@BIOkeyIntl Investors X:StockTwits:@BIO_keyIR@BIO_keyIR  Investor ContactsWilliam Jones, David CollinsCatalyst IRBKYI@catalyst-ir.com or 212-924-9800

Related News